Abstract
As research progresses, the intricate metabolic connections between depression and tryptophan, as well as kynurenine (KYN), have become increasingly evident. In studies investigating the relationship between KYN and depression, the conclusions reached thus far have been inconsistent. Therefore, we propose employing a two-sample mendelian randomization (MR) approach to further elucidate the relationship between KYN and depression. We utilized extensive data from large-scale genome-wide association studies to identify single nucleotide polymorphisms that act as instrumental variables for kynurenine and depression in European ancestry populations, ensuring compliance with MR assumptions. We employed five MR algorithms, namely, weighted median, MR-Egger, inverse variance weighted (IVW), simple mode, and weighted mode, with IVW as the primary analysis method. Sensitivity tests were conducted using Cochran’s Q test, MR-Egger intercept test, MR Pleiotropy Residual Sum and Outlier, and Leave-one-out analysis.The IVW analysis revealed that each standard deviation increase in kynurenine corresponded to a 1.4-fold increase in the risk of depression (OR = 1.351, 95% CI 1.110–1.645, P = 0.003). The direction of the effect size (positive or negative) was consistent with the findings from the other four algorithms. Sensitivity tests indicated no heterogeneity or horizontal pleiotropy among the instrumental variables. Elevated levels of kynurenine have a causal relationship with an increased risk of developing depression.
Similar content being viewed by others
Introduction
Depression is a prevalent mental disorder characterized by persistent low mood, reduced interest, and diminished pleasure, which can disrupt eating and sleeping patterns and, in severe cases, lead to suicide. The global incidence of depression has increased by almost 50% over the past 30 years, affecting more than 264 million people worldwide1. Of particular concern is the recurrent nature of depression2. Tryptophan metabolism, particularly involving serotonin (5-HT) and kynurenine (KYN), plays a crucial role in the development of depression. It is responsible for synthesizing essential neuroactive compounds, 5-HT, and KYN3,4,5,6. Antidepressants that target the reuptake of 5-HT in the synaptic cleft have proven effective and are among the most widely used medications worldwide for treating depression, highlighting the significance of 5-HT in depressive disorders4. In contrast, research on KYN is relatively limited. As investigations progress, the metabolic connections between tryptophan, 5-HT, and KYN are becoming increasingly intricate in the context of depression. Despite the extensive research on the relationship between KYN and depression, conclusions are inconsistent. Some studies indicate lower levels of KYN in individuals with depression compared to control groups, while others report no association between depression and KYN levels7,8. Additionally, certain studies suggest elevated KYN levels in individuals with depression9.
Mendelian randomization (MR) is a method that utilizes data from genome-wide association studies (GWAS) and leverages genetic variants, specifically single nucleotide polymorphisms (SNPs), strongly associated with an exposure (such as KYN) as instrumental variables (IVs) to determine the causal relationship between the exposure and the outcome of interest (such as depression). By relying on the random distribution of genetic variants, MR is less prone to confounding factors and reverse causality, reducing bias and resembling randomized controlled trials. Hence, the objective of this study is to elucidate the causal relationship between KYN and depression through a stringent two-sample MR analysis.
Method
Data source
The GWAS data for depression and KYN: Both are derived from the European population’s GWAS from IEU Open GWAS (https://gwas.mrcieu.ac.uk/), with GWAS IDs for depression and KYN being ieu-b-102 and met-a-375, respectively. The GWAS data for depression originate from a study involving 170,756 depression patients and 329,443 controls10. The GWAS data for KYN originate from a human blood metabolite study with a sample size of 781611. Refer to Table 1 for specific details.
This study reanalyzes public data and does not require ethical approval.
Method
Selection of instrumental variables
To perform two-sample MR analysis and investigate the causal relationship between KYN and depression, IVs need to meet certain assumptions: (1) The SNPs were significantly correlated with the exposure; (2) SNPs can only influence the outcome through exposure. The following steps were taken to select suitable IVs:
Single nucleotide SNPs associated with exposure: SNPs were selected from the GWAS data for KYN based on their association with KYN at a significance threshold of P < 5 × 10–6 (If SNPs are filtered based on a threshold of P < 5 × 10–8, after the exclusion of weak instruments and the removal of confounding steps, we only retained 2 SNPs, making it unfeasible to conduct MR analysis). SNPs exhibiting genomic linkage imbalance (distance window < 10,000 kb, linkage disequilibrium coefficient r2 < 0.001) were removed. The remaining SNPs were assessed for their F-statistic, and SNPs with F < 10, indicating weak instrumental variables, were excluded. Only SNPs with F > 10, demonstrating a significant association with the exposure, were retained12. The F-statistic was calculated using the formula F = (N−K−1) * R2/(1−R2), R2 = β2 (1—EAF) * 2EAF / SD2, where R2 represents the proportion of variation explained by each SNP, K is the number of SNPs, N is the total sample size, EAF is the allele frequency of the mutation, β is the beta coefficient related to the exposure factor, and SD is the variance13.
SNPs independent of outcome: SNPs associated with the outcome (depression) at a significance threshold of P < 5 × 10–8 were removed from the IVs. Palindromic variants with identical base pairs were also excluded to avoid potential double-counting of their variation. The remaining SNPs were verified against Phenoscanner (http://www.phenoscanner.medschl.cam.ac.uk/) to identify and exclude those influenced by confounding factors. The remaining SNPs meeting the MR assumptions were used as instrumental variables.
MR analysis
MR analysis was performed using five methods: Weighted median (WM), MR-Egger, inverse variance weighted (IVW), simple mode, and weighted mode. The IVW method served as the primary analysis. A significant result from the IVW analysis (P < 0.05) along with consistent effect directions (positive or negative) across the other four methods supports the inference of a causal relationship. This means that the results of these five algorithms are consistent, supporting the remarkable results of IVW. The IVW algorithm is a commonly used two-sample MR analysis method, which can make full use of the sample information of each study, thereby improving statistical power. When using other algorithms, some preprocessing of the data may be required, such as removing outliers, performing data transformation, etc., and these preprocessing may affect the results. The IVW algorithm requires less data and does not require special preprocessing, so the results may be more accurate. In addition, if the sample size is small or the sample distribution is uneven, the results of other algorithms may be more affected, and the IVW algorithm can maintain high statistical power in this case. When all SNPs adhere to the assumptions of MR, only under such conditions can the inverse variance weighted (IVW) method yield accurate estimates of causal relationships. The WM method leverages a majority of effective instrumental variables (IVs) for causal inference. MR-Egger, on the other hand, allows the inclusion of IVs that exhibit pleiotropy. The intercept is used to gauge horizontal pleiotropy, while the slope serves to ascertain causal relationships. A P-value less than 0.05 signifies that the results of the MR analysis carry significant statistical importance. The “TwoSampleMR” package in R 4.1.2 was utilized for all data processing.
Sensitivity analysis
Sensitivity tests were carried out to gauge the robustness of the findings. Cochran’s Q test was implemented to assess the heterogeneity among SNPs, with a P-value of less than 0.05 indicating significant heterogeneity. Techniques such as the MR-Egger intercept test and MR Pleiotropy Residual Sum and Outlier (MR-PRESSO) were deployed to investigate horizontal pleiotropy. If the intercept in the MR-Egger intercept test is statistically significant (P < 0.05), it implies a significant presence of pleiotropy. If the P-value of the MR-PRESSO result falls below 0.05, it suggests that the MR analysis presents considerable horizontal pleiotropy, which means that the IVs can directly influence the outcome without acting through the exposure factor. A leave-one-out analysis was conducted, which involved the sequential exclusion of each SNP to examine the impact on the combined effect of the remaining SNPs. Any notable alterations in the results due to the exclusion of a particular SNP suggests that the SNP has a substantial influence on the result, which infringes on the assumption of MR. The final results were presented using scatter plots, forest plots, and funnel plots.
Institutional review board statement
This study was based on a published database and did not require ethical approval.
Results
The MR analysis examined the causal relationship between KYN as the exposure and depression as the outcome. After applying the selection criteria, a total of 17 SNPs were identified as IVs that met the MR assumptions. Eight SNPs with F < 10 were excluded from the analysis, namely, rs3809198 (F = 0.83), rs16924894 (F = 1.46), rs16974854 (F = 1.74), rs11593042 (F = 3.50), rs511797 (F = 4.70), rs3789978 (F = 6.28), rs6575634 (F = 9.63), and rs2651516 (F = 9.97). No SNPs significantly associated with depression (P < 5 × 10–8) were found among the KYN SNPs extracted from the depression GWAS data. Palindromic variants were not detected. However, the SNP rs3184504 was identified as confounded by body mass index, which has been causally linked to depression in previous MR studies. Hence, this SNP was removed from the analysis14. Detailed results are presented in Table 2.
The IVW method, serving as the primary analysis, indicated that each standard deviation increase in KYN was associated with an approximately 1.4-fold increase in the risk of depression (OR = 1.351, 95% CI 1.110–1.645, P = 0.003). The effect directions from the other four methods were consistent with IVW. Further details can be found in Table 3.
Sensitivity analysis demonstrated no heterogeneity among the SNPs, as indicated by Cochran’s Q test (IVW: Q = 12.982, P = 0.674; MR-Egger: Q = 12.905, P = 0.610). The MR-Egger intercept test showed no evidence of horizontal pleiotropy (Intercept = − 0.001, P = 0.785). MR-PRESSO analysis did not identify any outliers (P = 0.719). The scatter plot illustrated the stability of the SNPs strongly associated with both KYN and depression (Fig. 1). The funnel plot displayed a symmetrical distribution of the SNPs, indicating no pleiotropy in the MR analysis (Fig. 2). Leave-one-out analysis demonstrated that the exclusion of individual SNPs did not significantly impact the overall results (Fig. 3).
Discussion
Emerging evidence points to the involvement of KYN, a metabolite of tryptophan, in the development of depression, with disruptions in the kynurenine pathway playing a significant role in the etiology of depression15,16. However, the relationship between KYN and depression remains unclear. This study endeavored to explore the causal relationship between KYN and depression using a two-sample MR approach. The research results provide robust evidence, indicating that an elevation in KYN levels significantly increases the risk of developing depression.
The chronic inflammation hypothesis of depression has garnered substantial literature support, positing depression as a neuroimmune disorder where the activation of the immune system plays a pivotal role in the onset and progression of depression17,18,19. Neuroinflammation is implicated in the regulation of the tryptophan-kynurenine (TRP-KYN) pathway, particularly modulated by various pro-inflammatory cytokines such as TNF-α, IL-6, INF-γ20,21. Previous observational studies have reported associations between abnormalities in tryptophan-kynurenine metabolism and depressive disorders, particularly in scenarios involving inflammation. These studies align with our findings, which demonstrate an increase in KYN levels in individuals with depression9,11,22,23,24,25. Some scholars have proposed a novel subtype of depression termed “immune-metabolic depression”, wherein alterations in inflammation, metabolism, and bioenergetic pathways are observed in the majority of individuals with depression26. Regrettably, given the current unavailability of GWAS data for immune-metabolic depression, we are unable to elucidate the causal relationship between KYN and immune-metabolic depression. If GWAS data for immune-metabolic depression and non-immune-metabolic depression become accessible in the future, a renewed MR analysis could be conducted to investigate the causal relationship between KYN and these two subtypes of depression. KYN may lean towards having a causal relationship with immune-metabolic depression. Future research might explore common genetic features between KYN and immune-metabolic depression in this direction.
Potential mechanisms underlying the link between KYN and depression may involve the induction of depressive-like behavior through increased expression of Nod-like receptor protein 2 (NLPR2) in astrocytes by KYN, mediated by proinflammatory cytokines4. Cytokines such as IL-1β, IL-6, and TNF-α can also inhibit the conversion of KYN to 5-HT by activating the kynurenine pathway, resulting in a decrease in 5-HT synthesis and the manifestation of depressive symptoms27.
Several limitations should be considered in interpreting the findings of this study. First, the data used in this analysis were derived from individuals of European ancestry, potentially limiting the generalizability of the results to other populations. Second, while various sensitivity analyses were conducted to assess the assumptions of the MR study, it is challenging to completely rule out the possibility of pleiotropy influencing the instrumental variables. Last, the sample size of the available GWAS datasets was limited, emphasizing the need for further research using larger and more diverse datasets.
Conclusions
In this study, we utilized a two-sample MR approach to investigate the causal relationship between KYN and depression. The findings provide compelling genetic evidence supporting a causal link between elevated levels of KYN and an increased risk of depression. This provides genetic evidence for understanding the etiological mechanisms of depression and potential interventions. Specifically, it prompts further exploration into whether the dysregulation of the KYN metabolic pathway is a pathogenic mechanism for depression, whether KYN can serve as a potential therapeutic target, or whether it can be used as a diagnostic or screening marker for depression. However, these findings warrant further investigation and validation.
Data availability
Publicly available datasets were analyzed in this study. These data can be found in the the MRC IEU Open GWAS Database. The script repository for this study is located at: https://github.com/zlxwy163/MR-Code/tree/main
References
Liu, Q. et al. Changes in the global burden of depression from 1990 to 2017: Findings from the global burden of disease study. J. Psychiatr. Res. 126, 134 (2020).
Monroe, S. M. & Harkness, K. L. Major depression and its recurrences: Life course matters. Annu. Rev. Clin. Psycho 18, 329 (2022).
Comai, S., Bertazzo, A., Brughera, M. & Crotti, S. Tryptophan in health and disease. Adv. Clin. Chem. 95, 165 (2020).
Correia, A. S. & Vale, N. Tryptophan metabolism in depression: A narrative review with a focus on serotonin and kynurenine pathways. Int. J. Mol. Sci. 23, 8493 (2022).
Badawy, A. A. Tryptophan availability for kynurenine pathway metabolism across the life span: Control mechanisms and focus on aging, exercise, diet and nutritional supplements. Neuropharmacology 112, 248 (2017).
Erhardt, S., Schwieler, L., Imbeault, S. & Engberg, G. The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112, 297 (2017).
Yang, J. et al. Assessing the causal effects of human serum metabolites on 5 major psychiatric disorders. Schizophrenia Bull. 46, 804 (2020).
Ogyu, K. et al. Kynurenine pathway in depression: A systematic review and meta-analysis. Neurosci. Biobehav. R 90, 16 (2018).
Raison, C. L. et al. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: Relationship to CNS immune responses and depression. Mol. Psychiatr. 15, 393 (2010).
Howard, D. M. et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nat. Neurosci. 22, 343 (2019).
Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543 (2014).
Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants. Int. J. Epidemiol. 40, 740 (2011).
Pang, L. et al. Causal relationship between smoking status, smoking frequency and bladder cancer: A mendelian randomization study. Genes Genom. 45, 203 (2023).
He, R. et al. Causal association between obesity, circulating glutamine levels, and depression: A mendelian randomization study. J. Clin. Endocr. Metab. 108(6), 1432–1441 (2022).
Brown, S. J. et al. Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: Evidence of a potential astrocyte pathology. J. Psychiatr. Res. 147, 203 (2022).
Doolin, K. et al. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Psychoneuroendocrino 95, 8 (2018).
Cakici, N. et al. Altered peripheral blood compounds in drug-naive first-episode patients with either schizophrenia or major depressive disorder: A meta-analysis. Brain Behav. Immun. 88, 547 (2020).
Zwicker, A. et al. Genetic disposition to inflammation and response to antidepressants in major depressive disorder. J. Psychiatr. Res. 105, 17 (2018).
Iob, E., Lacey, R. & Steptoe, A. Adverse childhood experiences and depressive symptoms in later life: Longitudinal mediation effects of inflammation. Brain Behav. Immun. 90, 97 (2020).
Kruse, J. L. et al. Kynurenine metabolism and inflammation-induced depressed mood: A human experimental study. Psychoneuroendocrino 109, 104371 (2019).
Carabelli, B. et al. Fish-oil supplementation decreases indoleamine-2,3-dioxygenase expression and increases hippocampal serotonin levels in the LPS depression model. Behav. Brain Res. 390, 112675 (2020).
Schwarcz, R., Bruno, J. P., Muchowski, P. J. & Wu, H. Q. Kynurenines in the mammalian brain: When physiology meets pathology. Nat. Rev. Neurosci. 13, 465 (2012).
Young, K. D. et al. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression. Brain Behav. Immun. 56, 335 (2016).
Paul, E. R. et al. Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav. Immun. 101, 136 (2022).
Gong, X., Chang, R., Zou, J., Tan, S. & Huang, Z. The role and mechanism of tryptophan - kynurenine metabolic pathway in depression. Rev. Neurosci. 34, 313 (2023).
Milaneschi, Y., Lamers, F., Berk, M. & Penninx, B. Depression heterogeneity and its biological underpinnings: Toward immunometabolic depression. Biol. Psychiat. 88, 369 (2020).
Miura, H. et al. A link between stress and depression: shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 11, 198 (2008).
Acknowledgements
We want to acknowledge the MRC IEU Open GWAS Database (https://gwas.mrcieu.ac.uk/) for publicly available GWAS data.
Funding
This work was supported by the Shandong Province Medical and Health Science and Technology Development Program Project (No. 202112070934).
Author information
Authors and Affiliations
Contributions
L.X.Z.: sofware, investigation, writing—original draft. M.H.G., J.M.W.: formal analysis. D.K., H.K.W.: methodology. Z.B.W., Z.R.H.: writing—review and editing. C.B.Z.: data curation. Q.M.J., M.H.C.: sofware, visualization. C.H.W.: supervision, writing—review and editing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zong, L., Ge, M., Wang, J. et al. Causal association between kynurenine and depression investigated using two-sample mendelian randomization. Sci Rep 14, 1821 (2024). https://doi.org/10.1038/s41598-024-52442-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-52442-4
- Springer Nature Limited